FDA Rejects Gilead’s Long-Acting HIV Drug Over Vial Issues
Summary : The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) to Gilead Sciences rejecting its New Drug Application…
Summary : The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) to Gilead Sciences rejecting its New Drug Application…
Summary : AbbVie has bolstered its neuropsychiatric and neurodegenerative portfolio with the acquisition of Belgium-based Syndesi Therapeutics in a deal valued at…
Winners Announced in 16th Annual Stevie® Awards for Sales & Customer Service New Categories for 2022 Recognize Thought Leadership FAIRFAX, Va., March…
Summary : – In the FDA-conducted study, SAB-185 consistently demonstrated high avidity and high potency for effectively neutralizing a broad range of…
Summary : Bruker PaSER™ 2022 software now features TIMS DIA-NN processing for dia-PASEF® Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with…
Synopsis : MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the grant…
Summary : A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the…
Summary : As the COVID-19 pandemic continues to claim lives around the world, dairy scientists may have a surprising role to play.…
Summary : The largest study to date has confirmed the link between the gut microbiome and the response to cancer immunotherapy therapy…
Summary : Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and…